MDWD MediWound Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: MDWD

Price (delayed)

$13.65

Market cap

$176.23M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.61

Enterprise value

$180.49M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 15

MediWound Ltd. is a global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair. The Company specializes in the development, production and commercialization of innovative biologics that enhance existing ...

Highlights
The EPS has increased by 39% year-on-year and by 29% since the previous quarter
The net income has grown by 29% YoY and by 23% from the previous quarter
The equity has surged by 77% year-on-year but it has declined by 14% since the previous quarter
The company's quick ratio has surged by 56% YoY but it fell by 4.1% QoQ
MDWD's gross profit is down by 50% year-on-year and by 35% since the previous quarter
MediWound's revenue has decreased by 40% YoY and by 18% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.mediwound.com
Peers: JNJ TEVA

Key stats

What are the main financial stats of MDWD

MDWD stock price

How has the MediWound stock price performed over time
Intraday
-2.15%
1 week
3.25%
1 month
3.33%
1 year
-23.57%
YTD
-26.06%
QTD
-7.14%

Financial performance

How have MediWound's revenue and profit performed over time
Revenue
$11.86M
Gross profit
$1.83M
Operating income
-$32.2M
Net income
-$20.18M
Gross margin
15.5%
Net margin
-170.1%
The company's operating margin has shrunk by 144% YoY and by 38% QoQ
MDWD's gross profit is down by 50% year-on-year and by 35% since the previous quarter
MDWD's operating income is down by 46% YoY and by 13% QoQ
MediWound's revenue has decreased by 40% YoY and by 18% from the previous quarter

Price vs fundamentals

How does MDWD's price correlate with its fundamentals

Growth

What is MediWound's growth rate over time

Valuation

What is MediWound stock price valuation
P/E
N/A
P/B
4.93
P/S
14.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.21
The EPS has increased by 39% year-on-year and by 29% since the previous quarter
The equity has surged by 77% year-on-year but it has declined by 14% since the previous quarter
MDWD's P/B is 36% below its 5-year quarterly average of 7.9 but 2.9% above its last 4 quarters average of 4.9
The P/S is 120% higher than the 5-year quarterly average of 6.9 and 17% higher than the last 4 quarters average of 13.0
MediWound's revenue has decreased by 40% YoY and by 18% from the previous quarter

Efficiency

How efficient is MediWound business performance
MDWD's ROE has soared by 51% YoY and by 30% QoQ
MDWD's ROIC is up by 43% year-on-year and by 3.6% since the previous quarter
The ROA has grown by 39% YoY and by 24% from the previous quarter
The return on sales has declined by 34% year-on-year and by 28% since the previous quarter

Dividends

What is MDWD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MDWD.

Financial health

How did MediWound financials performed over time
The company's total assets is 98% higher than its total liabilities
MDWD's current ratio has surged by 57% year-on-year but it is down by 3.7% since the previous quarter
The company's quick ratio has surged by 56% YoY but it fell by 4.1% QoQ
MediWound's debt is 76% lower than its equity
The equity has surged by 77% year-on-year but it has declined by 14% since the previous quarter
MediWound's debt to equity has decreased by 40% YoY but it has increased by 20% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.